Provided by Tiger Trade Technology Pte. Ltd.

Ocular Therapeutix

10.49
+0.13001.25%
Post-market: 10.540.0500+0.48%19:30 EDT
Volume:1.52M
Turnover:15.77M
Market Cap:2.30B
PE:-7.42
High:10.54
Open:10.30
Low:10.13
Close:10.36
52wk High:16.44
52wk Low:6.23
Shares:218.91M
Float Shares:185.00M
Volume Ratio:0.89
T/O Rate:0.82%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4140
EPS(LYR):-1.4203
ROE:-72.99%
ROA:-34.95%
PB:4.42
PE(LYR):-7.39

Loading ...

Sep 01, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 03, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 03, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 03, 2026

Major Issues Report

Form 8-K - Current report
Jul 30, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Jun 12, 2026

Major Issues Report

Form 8-K - Current report
Jun 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 27, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 26, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 26, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 26, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 05, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2026

Major Issues Report

Form 8-K - Current report
Feb 27, 2026

Major Issues Report

Form 8-K - Current report
Feb 24, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities